Titan Pharmaceuticals Inc (TTNP) — Cash Flow-to-Debt Ratio
Titan Pharmaceuticals Inc (TTNP) has a Cash Flow-to-Debt Ratio of -2.59x as of June 2025, meaning its operating cash flow of $-680.00K could theoretically repay -3% of its total liabilities ($263.00K) in one year. Check Titan Pharmaceuticals Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Titan Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1995–2024)
Historical debt coverage capacity for Titan Pharmaceuticals Inc across 30 annual periods. Also explore total assets of Titan Pharmaceuticals Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Titan Pharmaceuticals Inc (1995–2024)
Year-by-year debt coverage analysis for Titan Pharmaceuticals Inc. For market capitalisation and broader financial context, see TTNP stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -8.03x | $-3.88 Million | $483.00K | ▼ -63.6% |
| 2023 | -4.91x | $-7.09 Million | $1.44 Million | ▼ -61.8% |
| 2022 | -3.04x | $-8.18 Million | $2.69 Million | ▼ -9.8% |
| 2021 | -2.77x | $-7.90 Million | $2.86 Million | ▲ +26.8% |
| 2020 | -3.78x | $-17.20 Million | $4.55 Million | ▼ -97.8% |
| 2019 | -1.91x | $-15.45 Million | $8.09 Million | ▼ -64.5% |
| 2018 | -1.16x | $-8.43 Million | $7.26 Million | ▲ +28.4% |
| 2017 | -1.62x | $-13.04 Million | $8.05 Million | ▼ -241.0% |
| 2016 | 1.15x | $6.29 Million | $5.48 Million | ▲ +196.9% |
| 2015 | -1.19x | $-7.47 Million | $6.30 Million | ▼ -147.4% |
| 2014 | -0.48x | $-5.87 Million | $12.24 Million | ▲ +38.1% |
| 2013 | -0.77x | $-9.80 Million | $12.66 Million | ▼ -2127.8% |
| 2012 | 0.04x | $1.83 Million | $47.95 Million | ▲ +108.0% |
| 2011 | -0.48x | $-14.48 Million | $30.30 Million | ▼ -10.9% |
| 2010 | -0.43x | $-4.66 Million | $10.80 Million | ▲ +68.6% |
| 2009 | -1.37x | $-5.41 Million | $3.93 Million | ▲ +78.8% |
| 2008 | -6.50x | $-25.34 Million | $3.90 Million | ▼ -82.1% |
| 2007 | -3.57x | $-15.19 Million | $4.26 Million | ▲ +10.3% |
| 2006 | -3.98x | $-13.50 Million | $3.39 Million | ▲ +45.6% |
| 2005 | -7.31x | $-22.92 Million | $3.14 Million | ▼ -12.2% |
| 2004 | -6.51x | $-23.91 Million | $3.67 Million | ▲ +17.7% |
| 2003 | -7.91x | $-26.44 Million | $3.34 Million | ▼ -6.6% |
| 2002 | -7.42x | $-29.29 Million | $3.94 Million | ▼ -211.5% |
| 2001 | -2.38x | $-13.74 Million | $5.76 Million | ▲ +55.4% |
| 2000 | -5.34x | $-13.16 Million | $2.46 Million | ▲ +6.8% |
| 1999 | -5.74x | $-10.90 Million | $1.90 Million | ▲ +29.9% |
| 1998 | -8.19x | $-13.10 Million | $1.60 Million | ▼ -930.3% |
| 1997 | 0.99x | $7.10 Million | $7.20 Million | ▲ +134.7% |
| 1996 | -2.84x | $-10.80 Million | $3.80 Million | ▼ -207.3% |
| 1995 | -0.92x | $-8.60 Million | $9.30 Million | — |